Lucrin Depot, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze

7680519030489 CH-51903 Pulver
Lucrin Depot, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
Lucrin Depot, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
Lucrin Depot, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/07/2025
Summary of Product Characteristics
Français
22/07/2025
Summary of Product Characteristics
Italien
22/07/2025

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRS
3.75 MG Substance WIZUS
PRS
3.57 MG Substance Wirkstoff (Principe actif)
SOLV
0.54 MG Substance HBESI
PRS
- Substance HNIDK
SOLV
- Substance HNIDK
PRS
- Substance HNIDK
SOLV
- Substance HNIDK
PRS
- Substance HNIDK
SOLV
- Substance HNIDK
SOLV
- Substance HNIDK

Reimbursement information

Public price
CHF 150.90
Specialties list
Yes
Generic
No
SL addition date: 15/03/1994

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
51903
Drug name
Lucrin Depot, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
Galenic form
PULMR
ATC Code
L02AE02
Authorization status
Z
Dispensing category
A
First authorization
20/08/1993
Authorization expiration date
31/12/9999
IT Number
07.16.2.
Domain
Human medicine
Field of application
Prostatakarzinom, Endometriose, Mammakarzinom, zentrale vorzeitige Pubertät

Package details

Description (FR)
LUCRIN DEPOT PDS subst sèche 3.75 mg ser pré
Description (DE)
LUCRIN DEPOT PDS Trockensub 3.75 mg Fertspr
Market launch
15/10/2004
Narcotic (BTM)
No